Safety and Tolerability Evaluation Study of BVAC-B in Patients With HER2/Neu(Human Epithelial Growth Factor Receptor 2) Positive Gastric Cancer After Failure to Standard Care
Clinical trial NCT03425773 · COMPLETED
Trial details
- NCT number
- NCT03425773
- Sponsor
- Cellid Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-26
- Primary completion
- 2019-05-13
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.